The translation of new cancer-focused precision medical devices, often the width of a human hair, creates the opportunity to develop novel treatments for cancer patients. Currently, there is a gap for early-stage precision cancer medical device innovators creating functional prototypes essential for securing funding, attracting talent, and igniting strategic interest to advance toward products. In order to address this gap in Texas, and building upon the success of the Texas Medical Center Innovation's Accelerator for Cancer Therapeutics (ACT), we propose the Accelerator for Cancer Medical Devices (ACMD) to lower barriers of creating precision cancer-focused medical devices. In addition to p...
Read More
The translation of new cancer-focused precision medical devices, often the width of a human hair, creates the opportunity to develop novel treatments for cancer patients. Currently, there is a gap for early-stage precision cancer medical device innovators creating functional prototypes essential for securing funding, attracting talent, and igniting strategic interest to advance toward products. In order to address this gap in Texas, and building upon the success of the Texas Medical Center Innovation's Accelerator for Cancer Therapeutics (ACT), we propose the Accelerator for Cancer Medical Devices (ACMD) to lower barriers of creating precision cancer-focused medical devices. In addition to providing prototyping services, ACMD will provide resources such as: 1) a Device Business Management & Development Curriculum, 2) a Device Translation Curriculum, 3) a state-of-the-art device precision Prototyping Core Facility, and 4) an Educational Outreach Program to help innovators take their product to the clinic. Recognizing the shortage of resources for precision-engineered devices, the Prototyping Core aims to provide access to a high-resolution 3D printer and in silico simulation tools to enable early-stage investigators to move seamlessly from conceptualization to tangible prototypes. The ACMD curriculum provides best-in-class training, strategic mentorship, regulatory guidance, and extensive market assessment methods, all supported by Texas Medical Center’s (TMC) vibrant entrepreneurial ecosystem. Participants will graduate from the program with a prototype, a business plan, and a solid foundation in preclinical and clinical strategies—ensuring that their innovations can move from concept to commercial reality. Recognizing the opportunity in precision cancer medical device development, the ACMD will be coupled to the robust support from the TMC ecosystem and will foster innovation into impactful and life-changing cancer patient solutions in Texas and beyond.
Read Less
|
